GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Eone Diagnomics Genome Center Co Ltd (XKRX:245620) » Definitions » Research & Development

Eone Diagnomics Genome Center Co (XKRX:245620) Research & Development : ₩2,056 Mil (TTM As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Eone Diagnomics Genome Center Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Eone Diagnomics Genome Center Co's Research & Development for the three months ended in Mar. 2024 was ₩0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ₩2,056 Mil.


Eone Diagnomics Genome Center Co Research & Development Historical Data

The historical data trend for Eone Diagnomics Genome Center Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eone Diagnomics Genome Center Co Research & Development Chart

Eone Diagnomics Genome Center Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only 1,667.15 3,613.95 4,370.73 4,509.04 2,702.16

Eone Diagnomics Genome Center Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 646.26 1,440.36 415.76 199.78 -

Eone Diagnomics Genome Center Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩2,056 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eone Diagnomics Genome Center Co  (XKRX:245620) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Eone Diagnomics Genome Center Co Research & Development Related Terms

Thank you for viewing the detailed overview of Eone Diagnomics Genome Center Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Eone Diagnomics Genome Center Co (XKRX:245620) Business Description

Traded in Other Exchanges
N/A
Address
4th Floor, 291 Harmony-ro, Yeonsu-Gu, Incheon, KOR, 22014
Eeone Diagnomics Genome Center Co Ltd is engaged in developing and personalizing medicine based on Next Generation Sequencing technology and cutting edge genomics analysis. The company provides various personal genome sequencing and bioinformatics solutions to biomedical researchers, physicians and individuals seeking to understand the genetic influence of personal health and disease.

Eone Diagnomics Genome Center Co (XKRX:245620) Headlines

No Headlines